Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients
This study has been completed.
Sponsor:
Pfizer
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00174343
First received: September 9, 2005
Last updated: April 21, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2006 |
| Estimated Primary Completion Date: | No date given |